Valuation: Yuhan Corporation

Market Cap 5,482B 3.81B 3.32B 3.09B 2.83B 5.35B 364B 5.43B 36.38B 14.28B 181B 14.32B 14.01B 608B P/E 2026 *
40.6x
P/E 2027 * 26.6x
Enterprise Value 5.37B 3.74M 3.25M 3.02M 2.78M 5.24M 357M 5.33M 35.65M 13.99M 178M 14.04M 13.73M 596M EV / Sales 2026 *
2.27x
EV / Sales 2027 * 2.05x
Free-Float
64.28%
Yield 2026 *
0.76%
Yield 2027 * 0.76%
1 day-0.68%
1 week-1.87%
1 month+4.70%
3 months-19.76%
6 months-31.94%
Current year-34.61%
1 week 68,500
Extreme 68500
75,200
1 month 66,200
Extreme 66200
77,100
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
129,200
3 years 52,285.71
Extreme 52285.7143
166,900
5 years 47,571.43
Extreme 47571.4286
166,900
10 years 24,550.49
Extreme 24550.4865
166,900
Manager TitleAgeSince
Chief Executive Officer 71 2021-03-18
President 67 2024-03-14
Director of Finance/CFO 58 -
Director TitleAgeSince
Chairman 74 2021-03-18
Director/Board Member 71 2015-03-19
Director/Board Member 59 2021-03-18
Date Insider Type Main position Quantity % Market Cap.
6/30/25 Buy

Chairperson

200 0.0002%
6/25/25 Buy

Chief Executive Officer

720 0.0009%
6/24/25 Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-0.68%-1.87%-37.76%+5.72% 3.81B
+0.32%-0.66%+66.67%+22.08% 322B
+0.21%+2.87%+29.78%-10.42% 71.6B
-0.91%+0.74%+37.64%+92.13% 9.79B
-3.60%-2.43%-1.64%-5.95% 8.39B
+1.80%-1.99%-19.96%-2.95% 4.3B
+3.08%-1.41%-10.94%+5.60% 3.58B
-2.15%-3.40%+27.15%+45.42% 2.59B
+0.85%+9.88%-4.55%-6.36% 2.25B
-.--%+4.37%-22.93%-18.30% 1.76B
Average -0.11%-0.10%+6.35%+12.70% 42.96B
Weighted average by Cap. +0.21%-0.08%+55.11%+17.01%

Financials

2026 *2027 *
Net sales 2,365B 1.65B 1.43B 1.33B 1.22B 2.31B 157B 2.34B 15.69B 6.16B 78.19B 6.18B 6.04B 262B 2,574B 1.79B 1.56B 1.45B 1.33B 2.51B 171B 2.55B 17.08B 6.7B 85.1B 6.72B 6.58B 285B
Net income 147B 102M 88.65M 82.51M 75.76M 143M 9.73B 145M 973M 382M 4.85B 383M 375M 16.25B 206B 144M 125M 116M 107M 201M 13.7B 205M 1.37B 537M 6.82B 539M 527M 22.88B
Net Debt -109B -76.1M -66.15M -61.58M -56.53M -107M -7.26B -108M -726M -285M -3.62B -286M -280M -12.13B -194B -135M -117M -109M -100M -189M -12.89B -192M -1.29B -505M -6.42B -507M -496M -21.52B
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,087
Date Price Change Volume
26-07-31 ₩73,500.00 -0.68% 321,744
26-07-30 ₩74,000.00 +5.26% 404,762
26-07-29 ₩70,300.00 -0.57% 464,533
26-07-28 ₩70,700.00 -1.81% 229,612
26-07-27 ₩72,000.00 -3.87% 202,403
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
73,500.00KRW
Average target price
126,166.67KRW
Spread / Average Target
+71.66%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A000100 Stock